Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events

NCT02987946 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Deep-Venous Thrombosis

Interventions

DEVICE: IPD Device delivered by Converis
DRUG: Fraxiparine

Sponsor

Leiden University Medical Center

Collaborators

[object Object]